Activation of Embryonic Gene Transcription in Neural Precursor Cells Derived from the Induced Pluripotent Stem Cells of the Patients with Parkinson’s Disease-Reference-Cited by-同舟云学术

Activation of Embryonic Gene Transcription in Neural Precursor Cells Derived from the Induced Pluripotent Stem Cells of the Patients with Parkinson’s Disease

Published:2023-04 Issue:4 Volume:88 Page:515-525
ISSN:0006-2979
Container-title:Biochemistry (Moscow)
language:en
Short-container-title:Biochemistry Moscow

Author:

Fedoseyeva Viya B.,Novosadova Ekaterina V.,Nenasheva Valentina V.,Novosadova Lyudmila V.,Grivennikov Igor A.,Tarantul Vyacheslav Z.

Publisher

Pleiades Publishing Ltd

Subject

Biochemistry,General Medicine,Biochemistry, Genetics and Molecular Biology (miscellaneous),Biophysics,Geriatrics and Gerontology

Link

https://link.springer.com/content/pdf/10.1134/S0006297923040077.pdf

Reference69 articles.

1. De Lau, L. M., and Breteler, M. M. B. (2006) Epidemiology of Parkinson’s disease, Lancet Neurol., 5, 525-535, https://doi.org/10.1016/S1474-4422(06)70471-9.

2. Okano, H., and Yamanaka, S. (2014) iPS cell technologies: significance and applications to CNS regeneration and disease, Mol. Brain, 7, 22, https://doi.org/10.1186/1756-6606-7-22.

3. Day, J. O., and Mullin, S. (2021) The genetics of Parkinson’s disease and implications for clinical practice, Genes (Basel), 12, 1006, https://doi.org/10.3390/genes12071006.

4. Rathore, A. S., Birla, H., Singh, S. S., Zahra, W., Dilnashin, H., Singh, R., Keshri, P. K., and Singh, S. P. (2021) Epigenetic modulation in Parkinson’s disease and potential treatment therapies, Neurochem. Res., 46, 1618-1626, https://doi.org/10.1007/s11064-021-03334-w.

5. Rouaud, T., Corbillé, A.-G., Leclair-Visonneau, L., de Lataillade, A. G., Lionnet, A., Preterre, C., Damier, P., and Derkinderen, P. (2021) Pathophysiology of Parkinson’s disease: mitochondria, alpha-synuclein and much more, Rev. Neurol. (Paris), 177, 260-271, https://doi.org/10.1016/j.neurol.2020.07.016.